These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35908307)

  • 1. Determining the OPTIMAL DTI analysis method for application in cerebral small vessel disease.
    Egle M; Hilal S; Tuladhar AM; Pirpamer L; Bell S; Hofer E; Duering M; Wason J; Morris RG; Dichgans M; Schmidt R; Tozer DJ; Barrick TR; Chen C; de Leeuw FE; Markus HS
    Neuroimage Clin; 2022; 35():103114. PubMed ID: 35908307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion tensor image segmentation of the cerebrum provides a single measure of cerebral small vessel disease severity related to cognitive change.
    Williams OA; Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Mackinnon AD; Morris RG; Markus HS; Charlton RA; Barrick TR
    Neuroimage Clin; 2017; 16():330-342. PubMed ID: 28861335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of dementia using diffusion tensor MRI measures: the OPTIMAL collaboration.
    Egle M; Hilal S; Tuladhar AM; Pirpamer L; Hofer E; Duering M; Wason J; Morris RG; Dichgans M; Schmidt R; Tozer D; Chen C; de Leeuw FE; Markus HS
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):14-23. PubMed ID: 34509999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Dementia in Cerebral Small Vessel Disease Using an Automatic Diffusion Tensor Image Segmentation Technique.
    Williams OA; Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Mackinnon AD; Morris RG; Markus HS; Barrick TR; Charlton RA
    Stroke; 2019 Oct; 50(10):2775-2782. PubMed ID: 31510902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms.
    Baykara E; Gesierich B; Adam R; Tuladhar AM; Biesbroek JM; Koek HL; Ropele S; Jouvent E; ; Chabriat H; Ertl-Wagner B; Ewers M; Schmidt R; de Leeuw FE; Biessels GJ; Dichgans M; Duering M
    Ann Neurol; 2016 Oct; 80(4):581-92. PubMed ID: 27518166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peak Width of Skeletonized Mean Diffusivity: A Neuroimaging Marker for White Matter Injury.
    Zanon Zotin MC; Yilmaz P; Sveikata L; Schoemaker D; van Veluw SJ; Etherton MR; Charidimou A; Greenberg SM; Duering M; Viswanathan A
    Radiology; 2023 Mar; 306(3):e212780. PubMed ID: 36692402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage.
    Low A; Mak E; Stefaniak JD; Malpetti M; Nicastro N; Savulich G; Chouliaras L; Markus HS; Rowe JB; O'Brien JT
    Front Neurosci; 2020; 14():238. PubMed ID: 32265640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural network efficiency predicts cognitive decline in cerebral small vessel disease.
    Boot EM; Mc van Leijsen E; Bergkamp MI; Kessels RPC; Norris DG; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2020; 27():102325. PubMed ID: 32622317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in multimodal MRI markers predicts dementia risk in cerebral small vessel disease.
    Zeestraten EA; Lawrence AJ; Lambert C; Benjamin P; Brookes RL; Mackinnon AD; Morris RG; Barrick TR; Markus HS
    Neurology; 2017 Oct; 89(18):1869-1876. PubMed ID: 28978655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis.
    Vinciguerra C; Giorgio A; Zhang J; Di Donato I; Stromillo ML; Tappa Brocci R; Federico A; Dotti MT; De Stefano N
    Mult Scler Relat Disord; 2019 Jan; 27():294-297. PubMed ID: 30448470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletonized mean diffusivity and neuropsychological performance in relapsing-remitting multiple sclerosis.
    Chylińska M; Karaszewski B; Komendziński J; Wyszomirski A; Sabisz A; Halas M; Szurowska E
    Brain Behav; 2022 Jun; 12(6):e2591. PubMed ID: 35560868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of white-matter mask selection on DTI histogram-based metrics as potential biomarkers in cerebral small vessel disease.
    Fouto AR; Nunes RG; Pinto J; Alves L; Calado S; Gonçalves C; Rebolo M; Viana-Baptista M; Vilela P; Figueiredo P
    MAGMA; 2022 Oct; 35(5):779-790. PubMed ID: 34997895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.
    McCreary CR; Beaudin AE; Subotic A; Zwiers AM; Alvarez A; Charlton A; Goodyear BG; Frayne R; Smith EE
    Neuroimage Clin; 2020; 27():102280. PubMed ID: 32521475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter changes and gait decline in cerebral small vessel disease.
    van der Holst HM; Tuladhar AM; Zerbi V; van Uden IWM; de Laat KF; van Leijsen EMC; Ghafoorian M; Platel B; Bergkamp MI; van Norden AGW; Norris DG; van Dijk EJ; Kiliaan AJ; de Leeuw FE
    Neuroimage Clin; 2018; 17():731-738. PubMed ID: 29270357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.
    Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in rich club organization and cognition in cerebral small vessel disease.
    van Leijsen EMC; van Uden IWM; Bergkamp MI; van der Holst HM; Norris DG; Claassen JAHR; Kessels RPC; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2019; 24():102048. PubMed ID: 31706220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations.
    Zanon Zotin MC; Schoemaker D; Raposo N; Perosa V; Bretzner M; Sveikata L; Li Q; van Veluw SJ; Horn MJ; Etherton MR; Charidimou A; Gurol ME; Greenberg SM; Duering M; Dos Santos AC; Pontes-Neto OM; Viswanathan A
    Front Neurosci; 2022; 16():1051038. PubMed ID: 36440281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Blood Pressure Lowering Intensity With White Matter Network Integrity in Patients With Cerebral Small Vessel Disease.
    Pflanz CP; Egle MS; O'Brien JT; Morris RG; Barrick TR; Blamire AM; Ford GA; Tozer D; Markus HS;
    Neurology; 2022 Oct; 99(17):e1945-e1953. PubMed ID: 35977831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural brain network measures are superior to vascular burden scores in predicting early cognitive impairment in post stroke patients with small vessel disease.
    Du J; Wang Y; Zhi N; Geng J; Cao W; Yu L; Mi J; Zhou Y; Xu Q; Wen W; Sachdev P
    Neuroimage Clin; 2019; 22():101712. PubMed ID: 30772684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Diffusion Tensor Imaging Parameters to Detect Change in Longitudinal Studies in Cerebral Small Vessel Disease.
    Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Williams OA; Morris RG; Barrick TR; Markus HS
    PLoS One; 2016; 11(1):e0147836. PubMed ID: 26808982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.